Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment (The ATLANTIS trial): protocol for a randomised double-blind placebo-controlled trial in primary care

Overview of attention for article published in Trials, July 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

So far, Altmetric has seen 18 X posts from 15 X users, with an upper bound of 24,255 followers.

RT @Dr_SarahA: Our @AtlantisTrial protocol is now published! Amitriptyline or placebo for 2nd line irritable bowel syndrome: https://t.co…

Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment Read the ATLANTIS study protocol in #TrialsJournal @MedicalEvidence #ISRCTN: https://t.co/Fay9rJzrhT https://t.co/FJW6klspqV https://t.co/QCYILYII3F

RT @amanda_horler: Protocol paper out now for our @AtlantisTrial in #PrimaryCare - final results due in 2023 👀 @LeedsCTRU @ComplexCTRU @Lee…

RT @amanda_horler: Protocol paper out now for our @AtlantisTrial in #PrimaryCare - final results due in 2023 👀 @LeedsCTRU @ComplexCTRU @Lee…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 14 additional X posts.